Automated nitrogen analysis reduces costs per sample

N-Realizer analytical system from C. Gerhardt increases productivity with valve block from Festo

Prövning av pillervaccin mot covid-19 avbryts i USA

Det amerikanska hälsodepartementet har beordrat stopp för en statligt finansierad fas IIb-studie som skulle utvärdera ett potentiellt pillervaccin mot covid-19.

New Updates in Drug Formulation & Bioavailability 2026

Automated nitrogen analysis reduces costs per sample

N-Realizer analytical system from C. Gerhardt increases productivity with valve block from Festo

Genterapi mot blödarsjuka visade effekt ännu efter fyra år

Den omtalade genterapin Hemgenix mot hemofili B visar god effekt fortfarande fyra år efter att behandlingen utförts.

Nya notan för Purdue Pharma – skandalbolaget bakom opioidkrisen

Slutnotan kan vara på väg för läkemedelstillverkaren Purdue Pharmas inblandning i USA:s opioidkris – och den ser ut att landa på minst 7,4 miljarder dollar, mot...

Scale Up Your Image Analysis

ZEISS arivis Hub for accelerated analysis and faster results.

Sustainability at Festo

On the Way to the Net Zero Era - New Sustainability Report published

Large study on milk: Risky for women but not for men

The risk of ischemic heart disease (IHD) and acute myocardial infarction (MI) increased for women with milk intake levels higher than 2 glasses per day, while n...

Webinar: How to Plan And Analyze a Real-World Evidence Study

This webinar is for drug developers who want to understand the basic ideas of analyzing an RWE study, as well as avoiding the most common pitfalls.

Webinar: Clinical evaluation and clinical investigation of medical devices

Whether you are a small medtech company or a large one, this webinar is a must-attend for anyone curious about how clinical studies on medical devices are conducted.

Webinar: Medtech quality and regulatory compliance

This webinar is for you who are developing or planning to develop a medical device, combination, or borderline product. In one hour, we will discuss what you ne...

Webinar: What is Regulatory Affairs?

This webinar is intended for those who work within the life science sector and would like to gain a general understanding of regulatory affairs for human medicinal products.

Eternal Rye – Improving Plant Breeding Methods

User story from Martin Luther University Halle.

Clean solutions - Handling viscose substances with precision

Laboratories in the chemical, petrochemical, pharmaceutical and food technology industries are increasingly relying on automation for sample preparation. The Mo...

Första genterapin mot vanlig cancerform godkänd i USA

Den första genterapin mot urinblåsecancer har godkänts av den amerikanska läkemedelsmyndigheten FDA.

Anna Törner: The clinical trial – Periscope to reality

What happens to the patients in the clinical trial is not very interesting, writes Anna Törner in a column.

Theranos-skandalen – så gick det till när Elizabeth Holmes lurade USA:s toppinvesterare

Biotechbolaget Theranos var ett av de mest hyllade amerikanska företagen och dess vd Elizabeth Holmes blev en av USA:s yngsta miljardärer. Men 2015 vände allt f...

Founder of Bioarctic, Lars Lannfelt, is honoured: “I want to create something for the future”

It´s like a scientist’s dream: to be the world’s first with a drug that genuinely affects one of our major diseases. Lars Lannfelt and his company Bioarctic hav...

Första behandlingen mot sicklecellsjukdom godkänd

Första läkemedlet som angriper orsaken bakom sjukdomen får grönt ljus i USA – ”Har pågående diskussioner med EMA”

Lockdown-studie kritiseras även i USA

I USA har den uppmärksammade metastudie som uppger att knappt några liv har räddats med hjälp av lockdowns blivit kraftigt ifrågasatt av forskare.

Upcoming event: New updates on drugs

At Medicon Valley Alliance venues in Copenhagen/Örestad April 1 2020 the meeting New updates in Drug Formulation & Bioavailability takes place for the for the eighth time.

Ny CMO till Idogen

Idogen har rekryterat Steven Glazer som chief medical officer för att förstärka organisationen inför kommande kliniska studier.

Investments worth 40 billion in the Öresund region – “A huge investment wave”

A new report reveals that medical companies in the Oresund region are investing like never before.